[go: up one dir, main page]

SE9301582D0 - Purification of plasma proteins - Google Patents

Purification of plasma proteins

Info

Publication number
SE9301582D0
SE9301582D0 SE19939301582A SE9301582A SE9301582D0 SE 9301582 D0 SE9301582 D0 SE 9301582D0 SE 19939301582 A SE19939301582 A SE 19939301582A SE 9301582 A SE9301582 A SE 9301582A SE 9301582 D0 SE9301582 D0 SE 9301582D0
Authority
SE
Sweden
Prior art keywords
pct
aqueous phase
detergent
sec
salt
Prior art date
Application number
SE19939301582A
Other languages
English (en)
Swedish (sv)
Inventor
*Isaksson Sven
*Winge Stefan
Original Assignee
Kabi Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabi Pharmacia Ab filed Critical Kabi Pharmacia Ab
Priority to SE19939301582A priority Critical patent/SE9301582D0/xx
Publication of SE9301582D0 publication Critical patent/SE9301582D0/xx
Priority to CA002161804A priority patent/CA2161804C/en
Priority to PCT/SE1994/000422 priority patent/WO1994026287A1/en
Priority to DE69428356T priority patent/DE69428356T2/de
Priority to DK94915731T priority patent/DK0700300T3/da
Priority to NZ266234A priority patent/NZ266234A/en
Priority to ES94915731T priority patent/ES2164702T3/es
Priority to AT94915731T priority patent/ATE205719T1/de
Priority to JP52470494A priority patent/JP3771935B2/ja
Priority to PT94915731T priority patent/PT700300E/pt
Priority to EP94915731A priority patent/EP0700300B1/en
Priority to US08/537,872 priority patent/US5817765A/en
Priority to AU67634/94A priority patent/AU677332B2/en
Priority to NO19954428A priority patent/NO313084B1/no
Priority to FI955306A priority patent/FI113779B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/79—Transferrins, e.g. lactoferrins, ovotransferrins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/30—Extraction; Separation; Purification by precipitation
    • C07K1/303—Extraction; Separation; Purification by precipitation by salting out
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8125—Alpha-1-antitrypsin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Treatments Of Macromolecular Shaped Articles (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
SE19939301582A 1993-05-07 1993-05-07 Purification of plasma proteins SE9301582D0 (sv)

Priority Applications (15)

Application Number Priority Date Filing Date Title
SE19939301582A SE9301582D0 (sv) 1993-05-07 1993-05-07 Purification of plasma proteins
AU67634/94A AU677332B2 (en) 1993-05-07 1994-05-06 Purification of plasma proteins
ES94915731T ES2164702T3 (es) 1993-05-07 1994-05-06 Purificacion de proteinas plasmaticas.
JP52470494A JP3771935B2 (ja) 1993-05-07 1994-05-06 水溶性血漿タンパク質の純化方法
DE69428356T DE69428356T2 (de) 1993-05-07 1994-05-06 Reinigung von plasmaproteinen
DK94915731T DK0700300T3 (da) 1993-05-07 1994-05-06 Oprensning af plasmaproteiner
NZ266234A NZ266234A (en) 1993-05-07 1994-05-06 Process for purifying a plasma protein employing a salt to form vesicles containing virus-inactivating chemicals; the vesicles are then removed
CA002161804A CA2161804C (en) 1993-05-07 1994-05-06 Purification of plasma proteins
AT94915731T ATE205719T1 (de) 1993-05-07 1994-05-06 Reinigung von plasmaproteinen
PCT/SE1994/000422 WO1994026287A1 (en) 1993-05-07 1994-05-06 Purification of plasma proteins
PT94915731T PT700300E (pt) 1993-05-07 1994-05-06 Purificacao de proteinas do plasma
EP94915731A EP0700300B1 (en) 1993-05-07 1994-05-06 Purification of plasma proteins
US08/537,872 US5817765A (en) 1993-05-07 1994-05-06 Purification of plasma proteins
FI955306A FI113779B (fi) 1993-05-07 1995-11-06 Plasmaproteiinien puhdistus
NO19954428A NO313084B1 (no) 1993-05-07 1995-11-06 Fremgangsmåte for rensing av et vannopplöselig plasmaprotein

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE19939301582A SE9301582D0 (sv) 1993-05-07 1993-05-07 Purification of plasma proteins

Publications (1)

Publication Number Publication Date
SE9301582D0 true SE9301582D0 (sv) 1993-05-07

Family

ID=20389869

Family Applications (1)

Application Number Title Priority Date Filing Date
SE19939301582A SE9301582D0 (sv) 1993-05-07 1993-05-07 Purification of plasma proteins

Country Status (15)

Country Link
US (1) US5817765A (pt)
EP (1) EP0700300B1 (pt)
JP (1) JP3771935B2 (pt)
AT (1) ATE205719T1 (pt)
AU (1) AU677332B2 (pt)
CA (1) CA2161804C (pt)
DE (1) DE69428356T2 (pt)
DK (1) DK0700300T3 (pt)
ES (1) ES2164702T3 (pt)
FI (1) FI113779B (pt)
NO (1) NO313084B1 (pt)
NZ (1) NZ266234A (pt)
PT (1) PT700300E (pt)
SE (1) SE9301582D0 (pt)
WO (1) WO1994026287A1 (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9500724D0 (sv) 1994-06-23 1995-02-24 Pharmacia Ab Filtrering
ES2099678B1 (es) * 1995-11-03 1998-02-16 Grifols Grupo Sa Procedimiento para la inactivacion de virus en proteinas.
US6518406B1 (en) 1999-06-23 2003-02-11 Octapharma Ag Method for purification of proteins
SE9902388D0 (sv) * 1999-06-23 1999-06-23 Pharmacia & Upjohn Ab Method for purification of proteins
DE19932782A1 (de) * 1999-07-14 2001-01-18 Biotest Pharma Gmbh Verfahren zur chromatographischen Fraktionierung von Plasma oder Serum, so erhaltene Präparate und deren Verwendung
CN1192781C (zh) * 1999-12-20 2005-03-16 三菱制药株式会社 用多孔膜处理的无病毒血浆蛋白组合物及其生产方法
ATE428730T1 (de) * 2003-08-12 2009-05-15 Octapharma Ag Verfahren zur herstellung einer alpha-1- antitrypsinlösung
CA2572327A1 (en) * 2004-06-29 2006-02-02 Reliance Life Sciences Pvt. Ltd. Process for the preparation of virus-safe biological fluids
AU2005229674B2 (en) * 2004-11-18 2010-11-04 Kedrion Melville Inc. Low concentration solvent/detergent process of immuneglobulin with pre-treatment
US20100136584A1 (en) * 2008-09-22 2010-06-03 Icb International, Inc. Methods for using antibodies and analogs thereof
WO2010033913A1 (en) * 2008-09-22 2010-03-25 Icb International, Inc. Antibodies, analogs and uses thereof
US8980610B2 (en) 2008-11-20 2015-03-17 Biogen Idec Ma Inc. Arginine inactivation of viruses
CN102812118B (zh) * 2010-04-08 2016-01-20 恰根有限公司 分离和纯化核酸的方法
EP2395082A1 (en) 2010-06-14 2011-12-14 QIAGEN GmbH Extraction of nucleic acids from wax-embedded samples
US8921062B2 (en) 2010-11-09 2014-12-30 Quest Diagnostics Investments Incorporated Diagnostic and prognostic assays based on circulating tyrosine kinase activity
US10112988B2 (en) 2012-01-09 2018-10-30 Icb International, Inc. Methods of assessing amyloid-beta peptides in the central nervous system by blood-brain barrier permeable peptide compositions comprising a vab domain of a camelid single domain heavy chain antibody against an anti-amyloid-beta peptide
US10112987B2 (en) 2012-01-09 2018-10-30 Icb International, Inc. Blood-brain barrier permeable peptide compositions comprising a vab domain of a camelid single domain heavy chain antibody against an amyloid-beta peptide
HK1212995A1 (zh) * 2012-10-03 2016-06-24 Csl Behring Ag 一种纯化蛋白质的方法
US9534029B2 (en) 2012-10-03 2017-01-03 Csl Behring Ag Method of purifying proteins
CA3080656A1 (en) 2017-10-30 2019-05-09 Baxalta GmbH Environmentally compatible detergents for inactivation of lipid-enveloped viruses
US10815270B1 (en) * 2019-09-20 2020-10-27 Plasma Technologies, Llc Compositions and methods for high efficiency protein precipitation
KR20220079572A (ko) * 2019-09-20 2022-06-13 플라즈마 테크놀로지스, 엘엘씨 치료 단백질 조성물 및 방법(therapeutic protein compositions and methods)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4820805A (en) * 1983-07-14 1989-04-11 New York Blood Center, Inc. Undenatured virus-free trialkyl phosphate treated biologically active protein derivatives
US4540573A (en) * 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
US4764369A (en) * 1983-07-14 1988-08-16 New York Blood Center Inc. Undenatured virus-free biologically active protein derivatives
US4684723A (en) * 1985-09-11 1987-08-04 Miles Laboratories, Inc. Method of separating proteins from aqueous solutions
US4789545A (en) * 1986-03-31 1988-12-06 New York Blood Center, Inc. Removal of lipid soluble process chemicals from biological materials by extraction with naturally occurring oils or synthetic substitutes thereof
EP0367840B1 (de) * 1988-11-05 1993-02-03 Octapharma AG Verfahren zur Herstellung eines hochreinen, nicht infektiösen Antihämophiliefaktors mittels Chromatographie
US5395923A (en) * 1993-02-23 1995-03-07 Haemacure-Biotech, Inc. Process for the obtention of a biological adhesive made of concentrated coagulation factors by "salting-out"

Also Published As

Publication number Publication date
NZ266234A (en) 1996-06-25
EP0700300B1 (en) 2001-09-19
NO313084B1 (no) 2002-08-12
EP0700300A1 (en) 1996-03-13
CA2161804A1 (en) 1994-11-24
AU677332B2 (en) 1997-04-17
CA2161804C (en) 2003-12-02
NO954428L (no) 1995-11-06
DE69428356T2 (de) 2002-04-25
FI955306L (fi) 1995-11-06
ATE205719T1 (de) 2001-10-15
NO954428D0 (no) 1995-11-06
DE69428356D1 (de) 2001-10-25
FI955306A0 (fi) 1995-11-06
US5817765A (en) 1998-10-06
JP3771935B2 (ja) 2006-05-10
ES2164702T3 (es) 2002-03-01
JPH08509746A (ja) 1996-10-15
PT700300E (pt) 2002-03-28
AU6763494A (en) 1994-12-12
WO1994026287A1 (en) 1994-11-24
FI113779B (fi) 2004-06-15
DK0700300T3 (da) 2001-12-31

Similar Documents

Publication Publication Date Title
FI955306A0 (fi) Plasmaproteiinien puhdistus
DK0707594T3 (da) Adskillelse af proteiner
NO20031471L (no) Glykoformer av faktor VII
KR860008276A (ko) 단백질이 생성된 배양기로 부터 그것을 추출, 정제하는 방법
ATE235506T1 (de) Behandlung einer proteinlösung mit a1/fe und anschliesende membrankonzentration
ATE226213T1 (de) Verbindung der struktur aminosäure- hydroxyethylamino-sulfonamide als inhibitoren der retroviralen protease
FI911800A0 (fi) Enzymstabiliserande komposition och detergentkompositioner innehaollande ett stabiliserat enzym och en builder.
ATE216400T1 (de) Kristallisierbare zusammensetzungen, die einen komplex von protein-domäne ns3aus dem virus von hepatitis c und ns4a enthalten und damit bereitgestellte kristalle
IL122665A (en) Method and apparatus for inactivating contaminants in blood products
DK0722344T3 (da) Fremgangsmåde til virusinaktivering i nærvær af en polyether og et middel
DE59308628D1 (de) Verfahren zur Herstellung von Faktor VIII
ATE432946T1 (de) Abtrennung von fibrinogen von plasmaproteasen
DK1329461T3 (da) Fremgangsmåde til fjernelse af humane serum-albumin-polymerer
DE3763601D1 (de) Verfahren zum isolieren und reinigen von haemin.
DE69029471D1 (de) Wiedergewinnungsverfahren von mikrobiell erzeugtem chymosin
ES2196870T3 (es) Procedimiento para la purificacion o aislamiento de acidos nucleicos virales.
DE69811758D1 (de) Verwendung von Hyaluronsäure zur Herstellung einer wässrigen Lösung verwendbar als intra-artikulare Reinigungslösung
DK0512087T3 (da) Fremgangsmåde til reaktivering af denaturerede proteiner
NO994821L (no) Fremgangsmåte ved inaktivering av patogener, spesielt virus, i et biologisk materiale
ATE199556T1 (de) Verfahren zur fraktionierung von deacylierten glycerophospholipiden
JPS559036A (en) Purification of igm
DE60105760D1 (de) Verfahren zur behandlung von mitteln zur reinigung von abgasen
DE59611353D1 (de) Transketolase-verwandtes protein
SE9702993D0 (sv) Anti-mikrobial komposition
NO943024L (no) Vandige detergentblandinger inneholdende kalsiumioner for harde flater